Chemoinformaics analysis of DOCOSAHEXAENOIC-ACID
| Molecular Weight | 251.414 | nRot | 10 |
| Heavy Atom Molecular Weight | 222.182 | nRig | 3 |
| Exact Molecular Weight | 251.225 | nRing | 0 |
| Solubility: LogS | -3.498 | nHRing | 0 |
| Solubility: LogP | 4.547 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 47 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 29 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 47.959 |
| nHD | 1 | BPOL | 30.531 |
| QED | 0.457 |
| Synth | 2.525 |
| Natural Product Likeliness | 0.991 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.026 |
| Pgp-sub | 0.004 |
| HIA | 0.003 |
| CACO-2 | -4.512 |
| MDCK | 0.0000218 |
| BBB | 0.718 |
| PPB | 0.966177 |
| VDSS | 0.775 |
| FU | 0.032855 |
| CYP1A2-inh | 0.767 |
| CYP1A2-sub | 0.565 |
| CYP2c19-inh | 0.759 |
| CYP2c19-sub | 0.808 |
| CYP2c9-inh | 0.562 |
| CYP2c9-sub | 0.741 |
| CYP2d6-inh | 0.097 |
| CYP2d6-sub | 0.504 |
| CYP3a4-inh | 0.616 |
| CYP3a4-sub | 0.211 |
| CL | 6.373 |
| T12 | 0.665 |
| hERG | 0.246 |
| Ames | 0.02 |
| ROA | 0.511 |
| SkinSen | 0.968 |
| Carcinogencity | 0.318 |
| EI | 0.698 |
| Respiratory | 0.926 |
| NR-Aromatase | 0.01 |
| Antiviral | Yes |
| Prediction | 0.72102 |